Blinded, randomized study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella candidate vaccine given to healthy children during the second year of life
Combined Measles, Mumps, Rubella, Varicella Vaccine
Measles; Mumps; Rubella; Varicella
Phase 3
A follow on study 104690 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
October 2014